ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC

PrivateCIK: 1917529
Location

CAMBRIDGE, MA

πŸ“‹ What this filing means

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $803.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

15
Positions
$803.56M
Total AUM (reported)
73.69M
Total Shares

Allocation by class

TOTAL AUM$803.56M15 positions
COMMON STOCK$803.56M100.0%

Portfolio Concentration

Top 349.7%4–1044.8%11–255.4%TOP 1094.6%0%100%
Top 3$399.60M49.7%
4–10$360.33M44.8%
11–25$43.63M5.4%

Top 3 weight

49.7%

Top 10 weight

94.6%

Voting Authority Distribution

Total shares with voting rights: 73.69M

Sole

Full voting authority

73.69M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole15
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings15
Rows:

Disc Medicine, Inc.

SOLE
Common Stock
Shares3.46M
TypeSH
Market value$153.70M
19.13%
Sole
3.46M
Shared
0.00
None
0.00

Kymera Therapeutics, Inc.

SOLE
Common Stock
Shares5.86M
TypeSH
Market value$134.68M
16.76%
Sole
5.86M
Shared
0.00
None
0.00

Dyne Therapeutics, Inc.

SOLE
Common Stock
Shares9.89M
TypeSH
Market value$111.21M
13.84%
Sole
9.89M
Shared
0.00
None
0.00

Day One Biopharmaceuticals, Inc.

SOLE
Common Stock
Shares7.61M
TypeSH
Market value$90.84M
11.31%
Sole
7.61M
Shared
0.00
None
0.00

Vigil Neuroscience, Inc.

SOLE
Common Stock
Shares5.84M
TypeSH
Market value$54.87M
6.83%
Sole
5.84M
Shared
0.00
None
0.00

Third Harmonic Bio, Inc.

SOLE
Common Stock
Shares10.91M
TypeSH
Market value$52.47M
6.53%
Sole
10.91M
Shared
0.00
None
0.00

Replimune Group, Inc.

SOLE
Common Stock
Shares2.10M
TypeSH
Market value$48.72M
6.06%
Sole
2.10M
Shared
0.00
None
0.00

Generation Bio, Co.

SOLE
Common Stock
Shares8.28M
TypeSH
Market value$45.54M
5.67%
Sole
8.28M
Shared
0.00
None
0.00

Aerovate Therapeutics, Inc.

SOLE
Common Stock
Shares2.04M
TypeSH
Market value$34.97M
4.35%
Sole
2.04M
Shared
0.00
None
0.00

Ikena Oncology, Inc.

SOLE
Common Stock
Shares5.02M
TypeSH
Market value$32.92M
4.10%
Sole
5.02M
Shared
0.00
None
0.00

Akero Therapeutics, Inc.

SOLE
Common Stock
Shares594.25K
TypeSH
Market value$27.75M
3.45%
Sole
594.25K
Shared
0.00
None
0.00

Xilio Therapeutics, Inc.

SOLE
Common Stock
Shares2.76M
TypeSH
Market value$7.23M
0.90%
Sole
2.76M
Shared
0.00
None
0.00

AvroBio, Inc.

SOLE
Common Stock
Shares4.54M
TypeSH
Market value$4.31M
0.54%
Sole
4.54M
Shared
0.00
None
0.00

Magenta Therapeutics, Inc.

SOLE
Common Stock
Shares3.79M
TypeSH
Market value$2.87M
0.36%
Sole
3.79M
Shared
0.00
None
0.00

Spero Therapeutics, Inc.

SOLE
Common Stock
Shares1.01M
TypeSH
Market value$1.47M
0.18%
Sole
1.01M
Shared
0.00
None
0.00
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 13F Holdings β€” 15 Positions | Finecho